Methotrexate Sodium Market is Projected to Reach 1.58 $Billion by 2020

Date: 2016-09-11

Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system.

Along with global surging demand of medical service, Methotrexate sodium injection is estimated to act a key factor to Methotrexate Sodium growth, since geriatric population would cause many rheumatoid arthritis, Crohn’s disease, the research reveals the global Methotrexate Sodium is projected to reach 1.58 $Billion by 2020, and with 7.71% of CAGR during the forecast period 2016-2020. 

Additionally, early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function.

Other uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional. This medication may also be used for lupus, psoriatic arthritis, Crohn’s disease, and ectopic pregnancy.

Methotrexate is an abortifacient and is commonly used to terminate pregnancies during the early stages, generally in combination with misoprostol. It is also used to treat ectopic pregnancies, provided the fallopian tube has not ruptured.

Global Major leading Methotrexate Sodium Players as following:


Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 001-510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample